Navigation Links
UPDATE: OPC Connectivity Between TruBio Software and Nova FLEX Analyzers
Date:3/6/2009

SANTA CLARA, Calif., March 6 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for bioprocess applications, and Nova Biomedical, Waltham, MA, a world leader in biotechnology process monitoring announced the release of a TruBio(TM) plug-in for OPC connectivity between TruBio control software and Nova FLEX(R) analyzers. OPC is the de facto standard for data exchange between process control systems and different hardware platforms.

OPC-based communication between a Nova FLEX(R) and TruBio reduces errors or time delays of manual sampling, and provides automated reporting of results. More sophisticated process control strategies can be implemented, process parameters can be adjusted without human intervention, and, when process alarm conditions occur, off-site personnel can be alerted and/or automatic corrective action be taken. Additionally, all off-line Nova FLEX(R) data can be directly consolidated into the TruBio/DeltaV historian, or used in automated batch report generation for electronic records.

Basil Zimmo, Vice President of Software at Finesse, stated, "The Nova FLEX(R)-TruBio plug-in will reduce operating costs: printouts of standalone analyzer results will no longer have to be manually attached or tracked. Furthermore, this product will improve bioprocess quality and yield: programming a Nova FLEX(R) to automatically standardize an in-situ probe or using Nova FLEX(R) cell viability data in real-time algorithms will increase the accuracy and repeatability of control."

"By redefining the standard associated with offline data to include complete integration and the value of those data as they are applied to the bioprocess automatically, Nova and Finesse continue to provide the cutting edge technology required to bring the biotechnology industry into a new era of effectiveness and profitability, thereby allowing our customers real-time benefits that, until now, were impossible," said Lyle Peshek, National Sales Manager - Biotechnology at Nova Biomedical.

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at www.finesse.com.

About Nova Biomedical

Nova Biomedical is committed to continue its technology leadership with advanced products that provide better, faster diagnostic information. We continue to innovate biotechnology instruments that allow faster, more economical development of drugs and other therapeutic products.


'/>"/>
SOURCE Finesse Solutions, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
2. RG Global Corporate Update: First Coal Bed Methane Water Treatment Plant Near Completion; Expanding Water Treatment Applications
3. Update: Neurobiological Technologies Sets Date for Second Quarter Financial Results and Conference Call
4. Update: HYSTA Announces Dr. Qi Lu to Continue on as President of HYSTA, USA
5. Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
6. Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nations Premier High School Science Competition
7. Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400
8. OPC Connectivity Between TruBio Software and Nova FLEX Analyzers
9. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
10. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
11. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... CA (PRWEB) , ... February 20, 2017 , ... ... announced today the re-launch of “Crosswalk Insight: Oncology™” (Crosswalk), a unique precision medicine ... of Crosswalk can now be accessed through Inspirata’s diagnostic cockpit and is downloadable ...
(Date:2/20/2017)... -- Former NFL players who had repeated head injuries may not ... to a preliminary study released today that will be presented ... Boston , April 22 to 28, 2017. ... muscles and nerves work together, like walking, kicking and writing. ... Repeated ...
(Date:2/18/2017)... February 18, 2017 Kurzlehrgang ... bei adoptiven Zelltherapie-Studien, Poster legt metaproteomische Analyse des Darm-Mikrobioms ... ... bekanntgab, wird Dr. Yoav Peretz , Scientific Director ... Entwicklung von Assays zum Nachweis intrazellulärer Zytokine bei adoptiven ...
(Date:2/17/2017)... PUNE, India , February 17, 2017 /PRNewswire/ ... research report "Biomarkers Market by Product (Consumables, Service), ... Disorders), Application (Diagnostics Development, Drug Discovery and Development, ... MarketsandMarkets, the market is projected to reach USD ... in 2016, growing at a CAGR of 13.8% ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017 Former 9/11 Commission border ... Committee, Janice Kephart of Identity Strategy Partners, ... Donald Trump,s "Executive Order: Protecting the Nation From ... 2017):  "As President Trump,s ,Travel Ban, Executive ... now essentially banned the travel ban, it is important ...
(Date:2/8/2017)... Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... today reported financial results for its quarter and year ended ... quarter of 2016 was $3.9 million compared to $6.9 million ... fourth quarter of 2016 was $0.6 million compared to $2.6 ... the fourth quarter of 2016 was $0.5 million, or $0.02 ...
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... , its innovative, highly flexible and award winning ... customers. iMedNet is a proven Software-as-a-Service ... Electronic Data Capture (EDC), but also delivers an entire ...
Breaking Biology News(10 mins):